Interferences by factor VIII and lupus anticoagulant in the modified one‐stage assay for emicizumab
Haemophilia · 2023
DOI: 10.1111/hae.14873 ↗Kurz gefasst
Leserbrief in der Zeitschrift Haemophilia, 2023. Verfasst von Capucine Habay und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire d'Hématologie Biologique, AP-HP, Hôpital Necker Enfants Malades, Paris, France. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Hemostatics, Hemophilia A. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Laboratoire d'Hématologie Biologique, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
- Université Paris-Saclay, INSERM, Hémostase inflammation thrombose HITh U1176, Le Kremlin-Bicêtre, France.
- Laboratoire d'Hématologie Biologique, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
- Centre de Traitement de l'Hémophilie, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
ORCID-Profile: Claire Auditeau, Adeline Blandinières, Annie Harroche, Laurent Frenzel, Dominique Lasne
Zitieren
APA
Habay, C., Auditeau, C., Blandinières, A., Bentounes, N. K., Lavenu-Bombled, C., Harroche, A., Bally, C., Frenzel, L., Borgel, D., & Lasne, D. (2023). Interferences by factor VIII and lupus anticoagulant in the modified one‐stage assay for emicizumab. Haemophilia. https://doi.org/10.1111/hae.14873
Vancouver
Habay C, Auditeau C, Blandinières A, Bentounes NK, Lavenu-Bombled C, Harroche A, et al. Interferences by factor VIII and lupus anticoagulant in the modified one‐stage assay for emicizumab. Haemophilia. 2023. doi:10.1111/hae.14873
BibTeX
@article{Habay2023,
author = {Habay, Capucine and Auditeau, Claire and Blandinières, Adeline and Bentounes, Nûn K and Lavenu-Bombled, Cécile and Harroche, Annie and Bally, Cecile and Frenzel, Laurent and Borgel, Delphine and Lasne, Dominique},
title = {Interferences by factor VIII and lupus anticoagulant in the modified one‐stage assay for emicizumab},
journal = {Haemophilia},
year = {2023},
doi = {10.1111/hae.14873}
}
EUVIMED